Oncotarget

November 10, 2020

View Archive »

About The Cover

The cover for issue 45 of Oncotarget features Figure 3, "Representative images of whole tumor volume segmentation of the co-registered T1 post-contrast sequence and apparent diffusion coefficient (ADC) map, yielding the corresponding ADC histogram distribution utilized for data analysis," by Khan, et al.

Table of Contents

Research Perspectives

T-cell redirecting bispecific antibodies targeting BCMA for the treatment of multiple myeloma

T-cell redirecting bispecific antibodies targeting BCMA for the treatment of multiple myeloma

https://doi.org/10.18632/oncotarget.27792

Christie P.M. Verkleij, Kristine A. Frerichs, Marloes Broekmans, Saida Absalah, Patricia W.C. Maas-Bosman, Sandy Kruyswijk, Inger S. Nijhof, Tuna Mutis, Sonja Zweegman,  and Niels W.C.J. van de Donk
4076-4081
Abstract  |  PDF  |  Full Text  |  How to cite

Research Papers

The impact of the RASSF1C and PIWIL1 on DNA methylation: the identification of GMIP as a tumor suppressor

The impact of the RASSF1C and PIWIL1 on DNA methylation: the identification of GMIP as a tumor suppressor

https://doi.org/10.18632/oncotarget.27795

Yousef G. Amaar,  and Mark E. Reeves
4082-4092
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

Diffusion-weighted MR imaging histogram analysis in HIV positive and negative patients with primary central nervous system lymphoma as a predictor of outcome and tumor proliferation

Diffusion-weighted MR imaging histogram analysis in HIV positive and negative patients with primary central nervous system lymphoma as a predictor of outcome and tumor proliferation

https://doi.org/10.18632/oncotarget.27800

Bilal Khan, Insun Chong, Quinn Ostrom, Sara Ahmed, Dima Dandachi, Aikaterini Kotrotsou, Rivka Colen,  and Fanny Morón
4093-4103
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Podcast

Association between vitamin D and ovarian cancer development in BRCA1 mutation carriers

Association between vitamin D and ovarian cancer development in BRCA1 mutation carriers

https://doi.org/10.18632/oncotarget.27803

Tanja Pejovic, Sonali Joshi, Shawn Campbell, Sarah Thisted, Fuhua Xu,  and Jing Xu
4104-4114
Abstract  |  PDF  |  Full Text  |  How to cite

Baseline CD44v6-positive circulating tumor cells to predict first-line treatment failure in patients with metastatic colorectal cancer

Baseline CD44v6-positive circulating tumor cells to predict first-line treatment failure in patients with metastatic colorectal cancer

https://doi.org/10.18632/oncotarget.27794

Chiara Nicolazzo, Flavia Loreni, Salvatore Caponnetto, Valentina Magri, Anna Rita Vestri, Rita Zamarchi, Angela Gradilone, Antonella Facchinetti, Elisabetta Rossi, Enrico Cortesi,  and Paola Gazzaniga
4115-4122
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

Expression profiling on subclasses of primary parotid gland carcinomas

Expression profiling on subclasses of primary parotid gland carcinomas

https://doi.org/10.18632/oncotarget.27797

Jeannine Meinrath, Anja Haak, Nesrin Igci, Priya Dalvi, Christoph Arolt, Sonja Meemboor, Udo Siebolts, Hannah Eischeidt-Scholz, Claudia Wickenhauser, Inga Grünewald, Uta Drebber, Reinhard Büttner, Alexander Quaas, Jens-Peter Klußmann, Margarete Odenthal, Dirk Beutner,  and Moritz Meyer
4123-4137
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

HIC1 (Hypermethylated in Cancer 1) modulates the contractile activity of prostate stromal fibroblasts and directly regulates CXCL12 expression

HIC1 (Hypermethylated in Cancer 1) modulates the contractile activity of prostate stromal fibroblasts and directly regulates CXCL12 expression

https://doi.org/10.18632/oncotarget.27786

Marion Dubuissez, Sonia Paget, Souhila Abdelfettah, Nathalie Spruyt, Vanessa Dehennaut, Gaylor Boulay, Ingrid Loison, Clementine de Schutter, Brian R. Rood, Martine Duterque-Coquillaud, Xavier Leroy,  and Dominique Leprince
4138-4154
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

CPEB1 orchestrates a fine-tuning of miR-145-5p tumor-suppressive activity on TWIST1 translation in prostate cancer cells

CPEB1 orchestrates a fine-tuning of miR-145-5p tumor-suppressive activity on TWIST1 translation in prostate cancer cells

https://doi.org/10.18632/oncotarget.27806

Fatemeh Rajabi, Win-Yan Liu-Bordes, Marina Pinskaya, Foretek Dominika, Gueorgui Kratassiouk, Guillaume Pinna, Simona Nanni, Antonella Farsetti, Christian Gespach, Arturo Londoño-Vallejo,  and Irina Groisman
4155-4168
Abstract  |  PDF  |  Full Text  |  How to cite

Glasgow prognostic score is a better predictor of the long-term survival in patients with gastric cancer, compared to the modified Glasgow prognostic score or high-sensitivity modified Glasgow prognostic score

Glasgow prognostic score is a better predictor of the long-term survival in patients with gastric cancer, compared to the modified Glasgow prognostic score or high-sensitivity modified Glasgow prognostic score

https://doi.org/10.18632/oncotarget.27796

Noriyuki Hirahara, Takeshi Matsubara, Shunsuke Kaji, Yasunari Kawabata, Ryoji Hyakudomi, Tetsu Yamamoto, Yuki Uchida, Kazunari Ishitobi, Kiyoe Takai,  and Yoshitsugu Tajima
4169-4177
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

AKT isoforms have discrete expression in triple negative breast cancers and roles in cisplatin sensitivity

AKT isoforms have discrete expression in triple negative breast cancers and roles in cisplatin sensitivity

https://doi.org/10.18632/oncotarget.27746

Bhumika Wadhwa, Masroor Paddar, Sameer Khan, Sameer Mir, Philip A.Clarke, Anna M. Grabowska, Devanahalli G. Vijay,  and Fayaz Malik
4178-4194
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Press Release

Case Reports

Liquid biopsy and multi-analyte testing guided treatment of HER2 positive periampullary adenocarcinoma with durable complete response after trastuzumab based therapy

Liquid biopsy and multi-analyte testing guided treatment of HER2 positive periampullary adenocarcinoma with durable complete response after trastuzumab based therapy

https://doi.org/10.18632/oncotarget.27793

Rajnish Nagarkar, Darshana Patil, Sewanti Limaye, Pradip Devhare, Ashwini Ghaisas, Navin Srivastava, Sachin Apurwa, Sanket Patil, Jinumary John, Zarrine Raazi, Aditya Shreenivas, Janani Sambath, Ajay Srinivasan, Prashant Kumar, Dadasaheb Akolkar,  and Rajan Datar
4195-4200
Abstract  |  PDF  |  Full Text  |  How to cite


Copyright © 2024 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC